Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
FDA Approves Another Low Testosterone Gel Amid Review of Heart Risks June 9, 2014 Irvin Jackson Add Your Comments Although federal drug regulators are continuing to investigate the heart risks associated with low testosterone drugs, evaluating whether stronger warnings are needed and if restrictions on the medications are warranted, the FDA approved yet another new testosterone replacement therapy, which will be sold under the brand name Vogelxo Gel. Upsher-Smith Laboratories indicated in an announcement (PDF) last week that the FDA has approved Vogelxo Gel for sale in the United States. Vogelxo Gel joins a crowded field of other testosterone gels, creams, patches and injections, including AndroGel, Axiron, Testim, Foresta, AndroDerm and others, and serious concerns have been raised regarding the risks of heart problems associated with all testosterone replacement products. Learn More About Testosterone Lawsuits Testosterone Gel, Patches, Injections or other Treatments May Cause Heart Attacks, Strokes, Wrongful Death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Testosterone Lawsuits Testosterone Gel, Patches, Injections or other Treatments May Cause Heart Attacks, Strokes, Wrongful Death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The medications are approved for treatment of testosterone deficiency caused by hypogonadism, which the industry has termed “Low T.” However, concerns have surfaced in recent years about potential heart risks and widespread overuse of the medications as a means of restoring youth and vigor. Testosterone replacement therapy was once considered a “niche” treatment, with original estimates provided by the drug makers suggesting that only about one million men may require the medications due to confirmed testosterone deficiency associated with a medical condition known as hypogonadism. However, the industry now generates more than $2 billion in annual sales and tens of millions of men use the drugs. Following aggressive direct-to-consumer marketing of “Low T” treatments that encourage men to seek prescription treatments if they have experienced decreased energy levels, loss of libido, weight gain or other problems commonly associated with aging, the drugs have been commonly prescribed to many men who may not have had a medical need for the testosterone replacement therapy. Low Testosterone Drug Risks Concerns about the potential side effects of low testosterone gel treatments have gained widespread attention this year, after several studies suggested that certain men may face an increased risk of heart attacks, strokes and death while using a low testosterone drug. In November 2013, a study published in JAMA suggested that side effects of low T drugs may increase the risk of heart attacks, strokes, and death among older men with certain pre-existing heart problems. That research was followed by a study published in the medical journal PLOSOne in January 2014, which found that low T treatments may double the risk of heart attack for younger men with heart disease and men over the age of 65, regardless of their prior heart conditions. In response to the findings, the FDA launched a safety review of all testosterone replacement therapy on January 31, re-assessing the warnings provided with the medication and whether additional regulatory actions are needed. Testosterone Heart Injury Lawsuits A growing number of low testosterone lawsuits are now being pursued against the makers of AndroGel and other popular treatments, alleging that inadequate warnings were provided for consumers and the medical community about the potential heart risks. About 100 AndroGel lawsuits and other claims have been filed so far this year, and it is ultimately expected that several thousand complaints will be brought by individuals throughout the United States. All of the claims involve similar allegations that the drug makers failed to adequately research their products or warn about the risk of heart attacks, strokes, blood clots and other injuries associated with use of the medications. Plaintiffs often allege that they never would have agreed to use testosterone replacement therapy if they had been provided accurate information about the heart risks. Plaintiffs also accuse the drug makers of overhyping “low T,” resulting in many men being prescribed testosterone to combat the normal effects of aging and placing them at unnecessary risk of heart problems. Upsher-Smith has not set a date for the release of Vogelxo, but has already published the prescribing information (PDF), which does not appear contain any warnings about the risk of testosterone heart problems in its label, though it does warn of pulmonary embolism and deep vein thrombosis risks, both of which can affect the heart. Tags: AndroGel, Heart Attack, Stroke, Testosterone, Testosterone Gel, Upsher-Smith, Vogelxo Image Credit: ||| More Testosterone Lawsuit Stories Link Between Testosterone Drugs and Heart Risks Not Found in New Study June 19, 2023 Study’s Findings Question Link Between Testosterone Drugs and Blood Clots October 26, 2021 New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (Posted: today) A federal judge has appointed a special master to help parties involved in hair relaxer lawsuits potentially negotiate a settlement to resolve the litigation. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawyers To Meet With MDL Judge Amid “Contentious” Disputes Over Bellwether Discovery Plans (04/23/2025)More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (04/17/2025)Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025) Additional AFFF Ulcerative Colitis Lawsuits Added to Bellwether Discovery Pool (Posted: today) A federal judge has added three additional ulcerative colitis claims to a pool of AFFF lawsuits being prepared for early test trials. MORE ABOUT: AFFF LAWSUITFirefighter Unions File Class Action Lawsuit Over Cancer-Causing Chemicals in Protective Gear (04/25/2025)Pennsylvania Residents File Class Action Lawsuit Over Jet Fuel Pipeline Leak (03/31/2025)Apple Watch PFAS Lawsuit Alleges Toxic Chemicals in Wrist Bands Could Increase Cancer Risks (03/14/2025) Ozempic Blindness Lawsuit Claims Drug Caused NAION Side Effects (Posted: yesterday) A new lawsuit claims that the diabetes and weight loss drug, Ozempic, caused a woman to lose vision in her left eye. MORE ABOUT: OZEMPIC LAWSUITOzempic-Related Emergency Room Visits Are Often Caused by Gastrointestinal Issues: Study (04/23/2025)Ozempic Side Effects Caused Stomach Paralysis and Severe Abdominal Pain, Lawsuit Claims (04/18/2025)Ozempic Gastroparesis Lawsuit Filed Over Nausea, Severe Abdominal Pain (04/04/2025)
New Testosterone Guidelines Warn Against Unnecessary Use, Prefer Shots Over Transdermal Products January 10, 2020
Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (Posted: today) A federal judge has appointed a special master to help parties involved in hair relaxer lawsuits potentially negotiate a settlement to resolve the litigation. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawyers To Meet With MDL Judge Amid “Contentious” Disputes Over Bellwether Discovery Plans (04/23/2025)More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (04/17/2025)Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025)
Additional AFFF Ulcerative Colitis Lawsuits Added to Bellwether Discovery Pool (Posted: today) A federal judge has added three additional ulcerative colitis claims to a pool of AFFF lawsuits being prepared for early test trials. MORE ABOUT: AFFF LAWSUITFirefighter Unions File Class Action Lawsuit Over Cancer-Causing Chemicals in Protective Gear (04/25/2025)Pennsylvania Residents File Class Action Lawsuit Over Jet Fuel Pipeline Leak (03/31/2025)Apple Watch PFAS Lawsuit Alleges Toxic Chemicals in Wrist Bands Could Increase Cancer Risks (03/14/2025)
Ozempic Blindness Lawsuit Claims Drug Caused NAION Side Effects (Posted: yesterday) A new lawsuit claims that the diabetes and weight loss drug, Ozempic, caused a woman to lose vision in her left eye. MORE ABOUT: OZEMPIC LAWSUITOzempic-Related Emergency Room Visits Are Often Caused by Gastrointestinal Issues: Study (04/23/2025)Ozempic Side Effects Caused Stomach Paralysis and Severe Abdominal Pain, Lawsuit Claims (04/18/2025)Ozempic Gastroparesis Lawsuit Filed Over Nausea, Severe Abdominal Pain (04/04/2025)